Abstract
Experiences with the nonionic contrast medium Optiray® 300 were analyzed in 120 consecutive patients who underwent intravenous urography. Allergic diathesis was recorded prior to the examination in 12.5% of the patients, pretreatment was given in only 3 cases. The clinical safety of Optiray was outstanding, no adverse reactions were noted. Diagnostic quality of the radiographs was excellent in 78% and good in 22% of the cases. Optiray is considered to be a safe and effective contrast agent for use in intravenous excretory urography.
Similar content being viewed by others
References
Pollack, H. M., Banner, M. P.: Current status of excretory urography. Uroradiology.Urol. Clin. N. Amer., 12, 585 (1985).
Fritzsch, T., Krause, W., Weinmann, H. J.: Status of contrast media research in MRI, ultrasound and X-ray.Eur. Radiol., 2, 2 (1992).
Optiray (Ioversol). Monographie, Mallinckrodt Medical GmbH.
Grainger, R. G.: Optimum utilisation of intravascular radiological contrast media.Eur. Radiol., 2, 121 (1992).
Katayama, H., Yamaguchi, K., Kozuka, T., Takashima, T., Seez, P., Matsuura, K.: Adverse reactions to ionic and nonionic contrast media.Radiology, 175, 621 (1990).
Ring, J., Rothenberger, K. H.: Anaphylaktoide Reaktionen nach Infusion von Röntgenkontrastmitteln.Münch. Med. Wochenschr., 126, 657 (1984).
Tauber, R., Reimann, J., Kersting, H., Schmidt, U.: Prämedikation mit H1 und H2 Rezeptorantagonisten vor Applikation von Röntgenkontrastmitteln?Münch. Med. Wochenschr., 127, 1052 (1985).
Demos, T. C., Schiffer, M., Love, L., Waters, W. B., Moncada, R.: Normal excretory urography in patients with primary kidney neoplasms.Urol. Radiol., 7, 75 (1985).
Schrott, K. M., Behrends, B., Clauß, W., Kaufmann, J., Lehnert, J.: Iohexol in der Ausscheidungsurographie.Fortschr. Med., 7, 153 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koncz, P.M. Intravenous excretory urography using Optiray in office urology. International Urology and Nephrology 27, 257–260 (1995). https://doi.org/10.1007/BF02564759
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02564759